News

OSE Immunotherapeutics to Present at Annual Sachs Immuno-Oncology: BD&L and Investment Forum

NANTES, France, May 18, 2017 (GLOBE NEWSWIRE) — OSE Immunotherapeutics SA(ISIN:FR0012127173) (Mnémo:OSE) announced today that the Company will present at the upcoming “Annual Sachs Immuno-Oncology: BD&L and Investment Forum” being held on June 2, 2017, in Chicago, Illinois, in parallel to the international annual American Society of Clinical Oncology (ASCO) meeting.

2017-06-20T13:23:02+00:00